Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SY-5609 是一种选择性的非共价 CDK7 抑制剂(KD = 0.065 nM),具有抗肿瘤活性并抑制细胞凋亡。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,460 | 现货 | ||
2 mg | ¥ 2,170 | 现货 | ||
5 mg | ¥ 3,660 | 现货 | ||
10 mg | ¥ 5,330 | 现货 | ||
25 mg | 特惠询价 | 现货 | ||
50 mg | 特惠询价 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 4,160 | 现货 |
产品描述 | SY-5609 is a selective and noncovalent inhibitor of CDK7(KD = 0.065 nM) with antitumor activity and inhibits apoptosis. |
靶点活性 | CDK12:870 nM (Ki), CDK7:0.065 nM (Kd), CDK9:960 nM (Ki), CDK2:2600 nM (Ki) |
体外活性 | SY-5609 (126.4 pM-4 µM) has an EC50 of 5.6 nM in the HCC70 cell line[1]. SY-5609 (0.01-10000 nM) exhibits strong antiproliferative effects with IC50s of 1-6 nM in triple-negative breast cancer and ovarian cancer cells including HCC70, MDA-MB453, COV504, A2780, OVCAR3, CAOV3 cells. SY-5609 (100-500 nM) induces apoptosis in HCC70, MDA-MB-468, CAOV3, and OVCAR3 cells. In HCC70 cells, SY-5609 (100-500 nM) induces G2/M cell cycle arrest. SY-5609 (25-500 nM) inhibits the phosphorylation of CDK2 at Thr160 via loss of CAK function[2]. |
体内活性 | In Balb/c nude female mice with HCC70 cell lines, SY-5609 (2 mg/kg/day; orally) induces tumor regression with a plasma exposure of 261.28 ng h/mL, a Cmax of 50.67 ng/mL and an elimination half-life of 3.33 h[2]. |
别名 | CDK7-IN-3 |
分子量 | 490.46 |
分子式 | C23H26F3N6OP |
CAS No. | 2417302-07-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 36 mg/mL (73.4 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0389 mL | 10.1945 mL | 20.389 mL | 50.9726 mL |
5 mM | 0.4078 mL | 2.0389 mL | 4.0778 mL | 10.1945 mL | |
10 mM | 0.2039 mL | 1.0195 mL | 2.0389 mL | 5.0973 mL | |
20 mM | 0.1019 mL | 0.5097 mL | 1.0195 mL | 2.5486 mL | |
50 mM | 0.0408 mL | 0.2039 mL | 0.4078 mL | 1.0195 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SY-5609 2417302-07-7 Cell Cycle/Checkpoint CDK SY5609 SY 5609 CDK7-IN-3 Inhibitor inhibitor inhibit